Clinical Trial Details

Assessment of Primary Prevention Patients Receiving An ICD – Systematic Evaluation of ATP (APPRAISE ATP) (Protocol # C1924)

The primary objective is to understand the role of antitachycardia pacing (ATP) in primary prevention patients indicated for ICD therapy and programmed according to current guidance of higher rate cut-offs and therapy delays. The time to first all-cause shock will be tested in subjects with standard therapy (ATP and shocks) compared to subjects programmed to shock only to assess equivalency.

Learn More

Principal Investigator(s)

Sponsor(s)

Boston Scientific Corporation

Contact

Hospitalist at 203-358-8879 or [email protected]

Location

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.